Results 261 to 270 of about 235,116 (346)

Identifying Factors of Organoid Establishment in Pancreatic Cancer: A Prospective Observational Study. [PDF]

Cancer Med
Wansch K, Schneider F, Dölvers F, Kühn A, Dragomir MP, Joosten M, Hilfenhaus G, Vecchione L, Felsenstein M, Lerchbaumer M, Jürgensen C, Bahra M, Duwe G, Schäfer R, Stintzing S, Keilholz U, Neumann CCM, Pelzer U.   +17 more
europepmc   +1 more source

Single‐Cell RNA Sequencing and Bulk RNA Sequencing Revealed the Interplay Between Intratumoral Heterogeneity and the Tumor Microenvironment in Breast Cancer

Cancer Medicine, Volume 15, Issue 2, February 2026.
The figure shows single‐cell datasets of breast cancer collected from the GEO database, including estrogen receptor‐positive breast cancer, HER2‐positive breast cancer, and triple‐negative breast cancer. These datasets are used to analyze differences among breast cancer subtypes by studying the interactions among epithelial cells, fibroblasts ...
Yunlong Zhao, Xiaoyu Zhang, Yingying Wang, Xiaomin Yu, Fengchun Lv, Mingyu Gong, Xiu‐An Yang   +6 more
wiley   +1 more source

Ossification in pancreatic neoplasms: A report of three cases of neuroendocrine tumor, mucinous cystic neoplasm, and intraductal papillary mucinous neoplasm with review of the literature. [PDF]

Biomed Rep
Fukuma Y, Ishida M, Yasuda E, Nakanishi K, Kushiyama S, Tomioka A, Asakuma M, Hirose Y.   +7 more
europepmc   +1 more source

CT and MRI Manifestations of Pancreatic Hemangioma: A Literature Review and a New Case Report

Clinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Pancreatic hemangioma is an extremely rare benign tumor occurring in the pancreas. Preoperative diagnosis is challenging due to its lack of specificity in clinical manifestations and imaging examinations. A pancreatic lesion was found during physical examination of a 54‐year‐old woman who had no symptoms of abdominal discomfort.
Jing Zhang, Jingjing Chen, Dongmei Zou, Xu Cao   +3 more
wiley   +1 more source

Endoscopic Ultrasound With Fine-Needle Biopsy for Rare Pancreatic Metastasis: A Case Series of Neuroendocrine Transformation From Primary Prostate Cancer. [PDF]

ACG Case Rep J
Ramirez Ramirez O, Ley D, Vecchio E, Matkowskyj KA, Agni RM, McNeel D, Lang JM, Gopal DV.   +7 more
europepmc   +1 more source

Nanogel‐Mediated Immunotherapy to Tackle Cancer and Inflammatory Diseases

ChemistryEurope, Volume 4, Issue 2, February 2026.
Nanogels formed through self‐assembly, microemulsion, or precipitation polymerization method enable precise delivery of immunotherapeutic factors and immune cell targeting, thus effectively modulating immune responses. This review highlights recent advances in stimuli‐responsive nanogel design, underlying mechanisms, and their potentials to tackle ...
Ziwen Zhang, Jinxia Wang, Guang‐Zhi Jin, István Bányai, Dzmitry Shcharbin, Ivan Stoikov, Mingwu Shen, Xiangyang Shi   +7 more
wiley   +1 more source

Rotational migration in human pancreatic ductal organoids depends on actin and myosin activity. [PDF]

Commun Biol
Xie G, Modak C, Usman OH, Tan RWF, Coca N, De Jesus G, Wang YJ, Thirumalai D, Li X, Irianto J.   +9 more
europepmc   +1 more source

Genetic and Clinical Characteristics of Patients With Tumor Mutation Burden‐High Unresectable Pancreatic Cancer and the Efficacy of Pembrolizumab Treatment

Cancer Reports, Volume 9, Issue 2, February 2026.
ABSTRACT Background Pembrolizumab is approved for treating patients with advanced solid tumors exhibiting high tumor mutation burden (TMB), including pancreatic cancer. However, owing to the rarity of TMB‐high pancreatic cancer, its genetic and clinical characteristics, alongside the therapeutic effectiveness of pembrolizumab, remain unclear.
Yugo Kai, Kenji Ikezawa, Kazuhiro Kozumi, Makiko Urabe, Ryoji Takada, Takumi Kinomoto, Takanori Masumoto, Masaki Kawabata, Hiroki Kishimoto, Kana Hosokawa, Kaori Mukai, Tasuku Nakabori, Yuko Yamaguchi, Naotoshi Sugimoto, Kazuyoshi Ohkawa   +14 more
wiley   +1 more source

Cystic tumors of the pancreas: Current perspectives on diagnosis and management. [PDF]

World J Gastroenterol
Shumka N, Karagyozov PI.
europepmc   +1 more source

CEACAM6 silencing suppresses tumour growth and sensitises cholangiocarcinoma to cisplatin

Clinical and Translational Discovery, Volume 6, Issue 1, February 2026.
CEACAM6 has the potential to become a novel and independent prognostic biomarker in cholangiocarcinoma (CCA). Silencing CEACAM6 can inhibit CCA tumour growth and significantly enhance the chemosensitivity to cisplatin. This chemo‐sensitising effect is mediated through the disruption of ribosome biogenesis and impairment of DNA damage repair.
Shi‐Jia Dai, Jiang‐Qi Tan, Jia‐Qi Guo, Ya‐Nan Zhou, Teng Huang, Hao‐Lin Jiang, Yang Liu, Li‐Wei Dong, Zhen‐Gang Yuan   +8 more
wiley   +1 more source